Actively Recruiting
Safety and Pharmacokinetics of LY4088044 Given by IV or SC in Healthy Adults A Randomized, Double-Blind Study
Led by Eli Lilly and Company · Updated on 2026-10-07
104
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to study LY4088044 in healthy adult participants to understand how well it is tolerated and to identify any side effects. The study is a Phase 1, randomized, double-blind, placebo-controlled trial designed to gather basic science data on safety, tolerability, pharmacokinetics, and pharmacodynamics of LY4088044. The study is sponsored by Eli Lilly and Company and focuses on healthy adults between 18 and 65 years old. Participants will receive LY4088044 or placebo administered either intravenously IV or subcutaneously SC in different dosing parts single-ascending dose SAD IV, SAD SC, and multiple-ascending doses MAD IV. The study is organized in parallel groups with randomized allocation, and the dosing routes and schedules vary by part. The intervention aims to assess how the drug enters and leaves the bloodstream and its effects on protein levels in skin samples. Participants will be involved for up to approximately 92 weeks, excluding screening. During this time, blood tests will monitor LY4088044 levels and elimination, while skin samples will be analyzed for pharmacodynamic effects. Safety assessments include monitoring for serious adverse events related to the drug and routine evaluations such as vital signs, cardiac monitoring, and laboratory tests. The study tracks maximum drug concentration and exposure over about 190 days to evaluate treatment effects and tolerability.
CONDITIONS
Brief Title
A Study of LY4088044 in Healthy Participants
Research Team
T
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
P
Physicians interested in becoming principal investigators please contact
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here